Compare ADSK & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADSK | IQV |
|---|---|---|
| Founded | 1982 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4B | 43.1B |
| IPO Year | 1994 | 2013 |
| Metric | ADSK | IQV |
|---|---|---|
| Price | $207.36 | $270.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 26 | 16 |
| Target Price | ★ $335.04 | $227.13 |
| AVG Volume (30 Days) | ★ 1.9M | 1.3M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.15 | ★ 4.67 |
| EPS | ★ 4.64 | 1.61 |
| Revenue | $7,206,000,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $15.35 | $6.77 |
| Revenue Next Year | $10.36 | $5.89 |
| P/E Ratio | ★ $45.13 | $167.76 |
| Revenue Growth | 17.53 | ★ 41.60 |
| 52 Week Low | $185.50 | $154.50 |
| 52 Week High | $326.18 | $277.40 |
| Indicator | ADSK | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 35.05 | 61.81 |
| Support Level | $202.16 | $159.91 |
| Resistance Level | $218.90 | $271.80 |
| Average True Range (ATR) | 6.53 | 6.44 |
| MACD | -1.32 | -0.77 |
| Stochastic Oscillator | 15.73 | 74.11 |
Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.